Morgan Stanley’s Rennova Health, Inc. RNVA Stock Holding History

Morgan Stanley’s Portfolio RNVA Stock Details RNVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-3,153	Closed	-$86K	–	6746
2017 Q1	$86K	Buy	3,153 +3,113	+7,783%	+$103K	﹤0.01%	5652
2016 Q4	$1K	Buy	+40	New	+$2.27K	﹤0.01%	6492
2016 Q2	–	Hold	0	–	–	–	6813
2016 Q1	–	Hold	0	–	–	–	6867
2015 Q4	–	Hold	0	–	–	–	6934
2015 Q3	–	Hold	0	–	–	–	6852
2015 Q2	–	Hold	0	–	–	–	6862
2015 Q1	–	Hold	0	–	–	–	6762
2014 Q4	–	Hold	0	–	–	–	6776
2014 Q3	–	Hold	0	–	–	–	6755
2014 Q2	–	Hold	0	–	–	–	6684
2014 Q1	–	Hold	0	–	–	–	6621
2013 Q4	–	Hold	0	–	–	–	6384

Other funds holding RNVA

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Morgan Stanley's RNVA Position: Q2 2017 in Review

Morgan Stanley sold out of Rennova Health, Inc. (RNVA) in Q2 2017, closing a stake of 3,153 shares — an estimated $86K sold.

Morgan Stanley first reported a position in RNVA in Q4 2016 and held it in 2 quarters. The position peaked at $86K in Q1 2017. 8 funds tracked by Wall St. Rank hold RNVA as of Q2 2017.

Morgan Stanley reported no remaining Rennova Health, Inc. position as of Q2 2017 after selling out during the quarter.
Morgan Stanley sold 3,153 Rennova Health, Inc. shares in Q2 2017, an estimated $86K.
Morgan Stanley first reported a position in Rennova Health, Inc. in Q4 2016 and held it in 2 quarters.
Morgan Stanley's Rennova Health, Inc. position peaked at $86K in Q1 2017.
8 funds tracked by Wall St. Rank held Rennova Health, Inc. as of Q2 2017.

Based on Morgan Stanley's 13F filing for Q2 2017, filed 11 Aug 2017.